Ullern A, Holm K, Røssevold AH, Andresen NK, Bang C, Lingjærde OC, Naume B, Hov JR, Kyte JA(2024) Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancer Mol Oncol(in press) DOI 10.1002/1878-0261.13760, PubMed 39545921
Vandraas K, Reinertsen KV, Gudim HB, Bowen CA, Gjerdalen G, Schlichting E, Naume B, Sætersdal A(2024) [Not Available] Tidsskr Nor Laegeforen, 144(12) DOI 10.4045/tidsskr.24.0182, PubMed 39404245
Egeland EV, Seip K, Skourti E, Øy GF, Pettersen SJ, Pandya AD, Dahle MA, Haugen MH, Kristian A, Nakken S, Engebraaten O, Mælandsmo GM, Prasmickaite L(2024) The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy Br J Cancer, 131(10), 1656-1667 DOI 10.1038/s41416-024-02875-5, PubMed 39390250